Sharkey, Robert M.
Cornell University · Columbia University Irving Medical Center · Baylor University Medical Center · Massachusetts General Hospital · Dana-Farber Cancer Institute · Immunomedics (United States) · University of Colorado Cancer Center · Weill Cornell Medicine · Vanderbilt-Ingram Cancer Center
3 papers on CoChatORCID 0000-0003-1408-0905
Most cited papers
- Verified
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine
Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
Cited by 874
- Verified
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting
Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., McBride, W. J., Sharkey, R. M., & Chang, C.-H. (2006) · Proceedings of the National Academy of Sciences
Radiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research
Cited by 209
- Verified
Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
Sharkey, R. M., Karacay, H., Litwin, S., Rossi, E. A., McBride, W. J., Chang, C.-H., & Goldenberg, D. M. (2008) · Cancer Research
Radiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research
Cited by 75
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free